Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Collin M, Coon"'
Autor:
Jackson D. Harris, Collin M. Coon, Megan E. Doherty, Eamon A. McHugh, Margaret C. Warner, Conley L. Walters, Olivia M. Orahood, Abigail E. Loesch, David C. Hatfield, John C. Sitko, Erin A. Almand, J. Jordan Steel
Publikováno v:
Synthetic and Systems Biotechnology, Vol 7, Iss 2, Pp 671-676 (2022)
Per- and Polyfluorinated alkyl substances (PFAS) are a broad class of synthetic compounds that have fluorine substituted for hydrogen in several or all locations and are globally categorized as PFCs (perfluorochemicals; commonly called fluorinated ch
Externí odkaz:
https://doaj.org/article/53e2e98865d345928f7b81683df920bd
Autor:
Ryan D. Rykhus, Zachary V. Shepard, Alix Young, Hadley Frisby, Kailee A. Calder, Collin M. Coon, Justin A. Falk, Sydney R. McAndrews, Aspen Turner, Christina Chang, Johanna Michelsohn, Raegan Petch, Sarah M. Dieker, Benjamin H. Markworth, Kevin Alamo-Perez, Aaron J. Hosack, Jacob M. Berg, Christian Schmidt, Joachim Storsberg, Mark A. Brown
Publikováno v:
Diseases, Vol 6, Iss 1, p 2 (2017)
Over the past two decades, the biopharmaceutical industry has seen unprecedented expansion and innovation in concert with significant technological advancements. While the industry has experienced marked growth, the regulatory system in the United St
Externí odkaz:
https://doaj.org/article/5e9cf3a7fe05467885b3654892122f75
Autor:
Jackson D, Harris, Collin M, Coon, Megan E, Doherty, Eamon A, McHugh, Margaret C, Warner, Conley L, Walters, Olivia M, Orahood, Abigail E, Loesch, David C, Hatfield, John C, Sitko, Erin A, Almand, J Jordan, Steel
Publikováno v:
Synthetic and systems biotechnology. 7(2)
Per- and Polyfluorinated alkyl substances (PFAS) are a broad class of synthetic compounds that have fluorine substituted for hydrogen in several or all locations and are globally categorized as PFCs (perfluorochemicals; commonly called fluorinated ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19385ccd0160945761ba798346cd0e12
https://pubmed.ncbi.nlm.nih.gov/35224235
https://pubmed.ncbi.nlm.nih.gov/35224235
Autor:
Mark A. Brown, Johanna Michelsohn, Joachim Storsberg, Aaron J Hosack, Kailee A Calder, Ryan D Rykhus, Christina Chang, Christian Schmidt, Aspen Turner, Benjamin H Markworth, Jacob M Berg, Kevin Alamo-Perez, Alix Young, Justin A Falk, Raegan Petch, Sarah M Dieker, Zachary V Shepard, Sydney R McAndrews, Hadley Frisby, Collin M Coon
Publikováno v:
Diseases, Vol 6, Iss 1, p 2 (2017)
Diseases
Diseases
Over the past two decades, the biopharmaceutical industry has seen unprecedented expansion and innovation in concert with significant technological advancements. While the industry has experienced marked growth, the regulatory system in the United St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cdb64f1c05676a9f473bbdbcce0f2e6
https://www.mdpi.com/2079-9721/6/1/2
https://www.mdpi.com/2079-9721/6/1/2